Significant response of low-dose apatinib monotherapy in brain metastases of triple-negative breast cancer: A case report

RATIONALE: The potential efficacy of apatinib in patients with advanced triple-negative breast cancer (TNBC) has been observed in a previous phase II clinical study. However, there is no study to evaluate its efficacy and safety in TNBC patients with brain metastasis (BM). Here we report one case th...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ting, Wang, Shan-Bing, Lei, Kai-Jian, Jiang, Mao-Qiong, Jia, Yu-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358397/
https://www.ncbi.nlm.nih.gov/pubmed/30681587
http://dx.doi.org/10.1097/MD.0000000000014182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358397/
https://www.ncbi.nlm.nih.gov/pubmed/30681587
http://dx.doi.org/10.1097/MD.0000000000014182

Ejemplares similares